Select Page


As posted on the website of the American Children’s Cancer Organization

[COMMENT: Dr Adamson has been the Chair of the Children’s Oncology Group (COG), the world’s largest, cooperative children’s cancer research entity since 2009 (ARE)].


We are pleased to be able to announce that Dr. Peter Adamson, attending Physician in the Division of Oncology at The Children’s Hospital of Philadelphia (CHOP) has been named by President Obama to the National Cancer Advisory Board today. Many of you have raised your voices and expressed the importance of having a pediatric oncologist in the Board, so we are gratified to be able to make this announcement.

We are also pleased that this announcement comes as the Administration, including the National Cancer Institute (NCI), is scaling up the Precision Medicine Initiative, which was announced by President Obama in his State of the Union address earlier this year. This initiative aims to enable a new era of medicine through research and technology that empowers patients, researchers, and providers to work together toward development of individualized treatments. As a part of this initiative, the President has included a request for $70 million in funding for NCI to scale up efforts to identify genomic drivers in cancer and apply that knowledge to the development of more effective approaches to cancer treatment. The Initiative also calls for the development of a research cohort of a million or more participants.

As we work with the teams at NIH, FDA, and ONC to scale and shape the cohort and this Initiative as a whole, we are eager to work with you to ensure that the pediatric cancer community’s voices are heard. You can learn more about the Initiative and sign up for updates here: NIH will also be hosting a workshop on patient participation in the cohort on July 1 and 2, and I would encourage you to tune in and participate online. Information on ways to engage in that workshop is located here:

We were pleased to be able to bring the pediatric cancer community together last September and hope to continue to build upon the dialogue we began at that convening, including the announcement that the White House Office of Management and Budget would be disaggregating spending in a way that would report pediatric cancer research totals.


Fae M. Jencks
Senior Policy Advisor for Public Engagement
White House Office of Science and Technology Policy
202-456-6008 |